This, in turn, activates the TLR4 receptor, triggering pathways such as NF-κB and MAPK, which promote insulin resistance through mechanisms like IRS-1 serine phosphorylation, as well as hyperandrogenemia and ovarian dysfunction (38, 39). The gene discussed is NFKB1; the disease is polycystic ovary syndrome.